Markers of inflammation as risk predictors of lethal outcome in patients diagnosed with delirium

  • Ivana Stašević Karličić Clinic for Psychiatric Disorders “Dr Laza Lazarević”, Belgrade, Serbia
  • Milena Stašević Clinic for Psychiatric Disorders “Dr Laza Lazarević”, Belgrade, Serbia
  • Slobodan Janković Clinic for Pharmacology, Toxicology and Clinical Pharmacology, Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
  • Slavica Djukić Dejanović Clinic for Pharmacology, Toxicology and Clinical Pharmacology, Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
  • Srdjan Milovanović Clinic for Psychiatry, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Keywords: delirium, intensive care units, inflammation, biological markers, c-reactive protein, prognosis,

Abstract


Background/Aim. Delirium is an acute or subacute, and most frequently reversible syndrome of higher cortical functions disturbances that is manifested as generalized disorder. If not prevented, it is associated with various adverse outcomes. The aim of this study was to determine the connection between the markers of inflammation and lethal outcome in patients diagnosed with delirium, hospitalized in the psychiatric intensive care unit. Methods. This retrospective study included 120 patients hospitalized in the psychiatric intensive care unit in whom examination of differences in inflammation markers was done. The examinees have been divided into two groups: the case group of 40 patients who died during the hospitalization, and the control group of 80 examinees who were discharged with the diagnosis Post delirium status. The following variables were taken into account: age, gender, clinical diagnosis of infection (pneumonia and urinary tract infection), laboratory parameters (total of white blood cells, granulocytes, monocytes, C-reactive protein − CRP) and type of delirium (withdrawal or organic). Results. The average age of the patients was 50.3 ± 13.1 years. The patients who survived delirium, were on the average 10.5 years younger than the deceased (p < 0.001). More than half (57.5%) of the deceased had pneumonia. There was a statistically significant correlation between pneumonia and lethal outcome in the patients with delirium (p < 0.001). The examinees with lethal outcome had significantly higher median CRP levels than the group of examinees who survived (75.6% ± 54.0 vs 30.3 ± 42.5 ng/L, p < 0.001). Conclusion. Aiming to better and more precise diagnostics of this complicated and still unclear neuropsychiatric syndrome it would be useful to consider introduction of more precise diagnostic algorithms in every unit of intensive care. That would significantly reduce the number of delirium diagnosis overlook, decrease complication of clinical features and would also reduce the unfavorable outcome rate, therefore the total cost of treatment.

References

Gelder GM, Andreasen CN, Lopez-Ibor JJ, Geddes RJ. New Oxford Text book of Psychiatry. Oxford, UK: Oxford University Press; 2009.

Eeles EM, Hubbard RE, White SV, O'Mahony M, Savva GM, Bayer AJ. Hospital use, institutionalisation and mortality associated with delirium. Age Ageing 2010; 39(4): 470−5.

McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely WE, et al. Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 2011; 15(2): R78.

Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123(6): 2043−9.

Pepersack T, de Breucker S. Could geriatric comprehensive as-sessment predict the outcome of pneumonia in the very old. Age Ageing 2007; 36(4): 455−9.

Zhang Z, Pan L, Deng H, Ni H, Xu X. Prediction of delirium in critically ill patients with elevated C-reactive protein. J Crit Care 2014; 29(1): 88−92.

MacDonald A, Adamis D, Treloar A, Martin F. C-reactive protein levels predict the incidence of delirium and recovery from it. Age Ageing 2007; 36(2): 222−5.

Tsuruta R, Nakahara T, Miyauchi T, Kutsuna S, Ogino Y, Yamamoto T, et al.. Prevalence and associated factors for delirium in critically ill patients at a Japanese intensive care unit. Gen Hosp Psychiatry 2010; 32(6): 607−11.

Zhang Z, Pan L, Ni H. Impact of delirium on clinical outcome in critically ill patients: a meta-analysis. Gen Hosp Psychiatry 2013; 35(2): 105−11.

Salluh JI, Soares M, Teles JM, Ceraso D, Raimondi N, Nava VS, et al. Delirium epidemiology in critical care (DECCA): an inter-national study. Crit Care 2010; 14(6): R210.

Ely WE, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, et al. Delirium as a predictor of mortality in mechanically ven-tilated patients in the intensive care unit. JAMA 2004; 291(14): 1753−62.

Lin SM, Liu CY, Wang CH, Lin CH, Huang CD, Huang PY, et al. The impact of delirium on the survival of mechanically ven-tilated patients. Crit Care Med 2004; 32(11): 2254−9.

Lin SM, Huang CD, Liu CY, Lin HC, Wang CH, Huang PY, et al. Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J Crit Care 2008; 23(3): 372−9.

Ouimet S, Riker R, Bergeron N, Bergeon N, Cossette M, Kavanagh B, et al. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007; 33(6): 1007−13.

Shehabi Y, Riker RR, Bokesch PM, Wisemandle W, Shintani A, Ely WE. Delirium duration and mortality in lightly sedated, me-chanically ventilated intensive care patients. Crit Care Med 2010; 38(12): 2311−8.

Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely WE. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilatet patients. Crit Care 2005; 9(4): R375−81.

van den Boogaard M, Peters SA, van der Hoeven JG, Dagnelie PC, Leffers P, Pickkers P, et al. The impact of delirium on the pre-diction of in-hospital mortality in intensive care patients. Crit Care 2010; 14(4): R146.

van den Boogaard M, Schoonhoven L, van der Hoeven JG, van Achter-berg T, Pickkers P. Incidence and short-term consequences of delirium in critically ill patients: A prospective observational cohort study. Int J Nurs Stud 2012; 49(7): 775−83.

Mariz J, Santos NC, Afonso H, Rodrigues P, Faria A, Sousa N, et al. Risk and clinical-outcome indicators of delirium in an emergency department intermediate care unit (EDIMCU): an observational prospective study. BMC Emerg Med 2013; 13(1): 2.

Yamaguchi T, Tsukioka E, Kishi Y. Outcomes after delirium in a Japanese intensive care unit. Gen Hosp Psychiatry 2014; 36(6): 634−6.

Sharma A, Malhotra S, Grover S, Jindal SK. Incidence, prevalence, risk factor and outcome of delirium in intensive care unit: a study from India. Gen Hosp Psychiatry 2012; 34(6): 639−46.

Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing 2006; 35(4): 350−64.

Dusemund F, Chronis J, Baty F, Albrich CY, Brutsche MH. The outcome of community-acquired pneumonia in patients with chronic lung disease. Swiss Med Wkly 2014; 144: w14013.

Calle A, Márquez MA, Arellano M, Pérez LM, Pi-Figueras M, Mi-ralles R. Geriatric assessment and prognostic factors of mortality in very elderly patients with community-acquired pneumonia. Arch Bronconeumol 2014; 50(10): 429−34. (English, Spanish)

Marrie T. Community-Acquired Pneumonia in the Elderly. Clin Infect Dis 2000; 31(4): 1066−78.

Ewig S, Kleinfeld T, Bauer T, Seifert K, Schäfer H, Göke N. Com-parative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J 1999; 14(2): 370−5.

Riquelme R, Torres A, el-Ebiary M, Mensa J, Estruch R, Ruiz M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 1997; 156(6): 1908−14.

de Zuazu HM, López GT, Barandiaran FA, Irujo OV, López MA. Neumonía en el anciano. Factores relacionados con la mortali-dad durante el episodio y tras el alta hospitalaria. Med Clin 2004; 123(9): 332−6. (Italian)

Adamis D, Treloar A, Darwiche F, Gregson N, Macdonald AJ, Mar-tin FC. Associations of delirium with in-hospital and in 6-months mortality in elderly medical inpatients. Age Ageing 2007; 36(6): 644−9.

Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JU. Di-agnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30(3): 529−35.

Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2001; 19(1): 53−61.

Panichi V, Migliori M, de Pietro S, Taccola D, Bianchi AM, Norpoth M, et al. C-reactive protein as a marker of chronic inflamma-tion in uremic patients. Blood Purif 2000; 18(3): 183−90.

Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 383(9920): 911−22.

Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK. One-year health care costs associated with delirium in the el-derly population. Arch Intern Med 2008; 168(1): 27−32.

WHO Regional Office for Europe. European hospital morbidity database. Copenhagen: WHO Regional Office for Europe; 2012.

Organization for Economic Co-operation and Development. OECD health data 2012. Paris: Organization for Economic Co-operation and Development; 2012.

Published
2017/03/10
Section
Original Paper